Markov OV - Search Results

1

Influence of Combinations of Lipophilic and Phosphate Backbone Modifications on Cellular Uptake of Modified Oligonucleotides.

Zharkov TD, Markov OV, Zhukov SA, Khodyreva SN, Kupryushkin MS. Zharkov TD, et al. Among authors: markov ov. Molecules. 2024 Jan 17;29(2):452. doi: 10.3390/molecules29020452. Molecules. 2024. PMID: 38257365 Free PMC article.

2

Transport Oligonucleotides-A Novel System for Intracellular Delivery of Antisense Therapeutics.

Markov OV, Filatov AV, Kupryushkin MS, Chernikov IV, Patutina OA, Strunov AA, Chernolovskaya EL, Vlassov VV, Pyshnyi DV, Zenkova MA. Markov OV, et al. Molecules. 2020 Aug 11;25(16):3663. doi: 10.3390/molecules25163663. Molecules. 2020. PMID: 32796768 Free PMC article.

3

Fork- and Comb-like Lipophilic Structures: Different Chemical Approaches to the Synthesis of Oligonucleotides with Multiple Dodecyl Residues.

Zharkov TD, Mironova EM, Markov OV, Zhukov SA, Khodyreva SN, Kupryushkin MS. Zharkov TD, et al. Among authors: markov ov. Int J Mol Sci. 2023 Sep 27;24(19):14637. doi: 10.3390/ijms241914637. Int J Mol Sci. 2023. PMID: 37834092 Free PMC article.

4

Symmetric lipophilic polyamines exhibiting antitumor activity.

Perevoshchikova KA, Eshtukova-Shcheglova EA, Markov OV, Markov AV, Chernikov IV, Maslov MA, Zenkova MA. Perevoshchikova KA, et al. Among authors: markov ov. Bioorg Med Chem. 2022 Dec 15;76:117089. doi: 10.1016/j.bmc.2022.117089. Epub 2022 Nov 5. Bioorg Med Chem. 2022. PMID: 36399911

5

Novel Efficient Lipid-Based Delivery Systems Enable a Delayed Uptake and Sustained Expression of mRNA in Human Cells and Mouse Tissues.

Fedorovskiy AG, Antropov DN, Dome AS, Puchkov PA, Makarova DM, Konopleva MV, Matveeva AM, Panova EA, Shmendel EV, Maslov MA, Dmitriev SE, Stepanov GA, Markov OV. Fedorovskiy AG, et al. Among authors: markov ov. Pharmaceutics. 2024 May 19;16(5):684. doi: 10.3390/pharmaceutics16050684. Pharmaceutics. 2024. PMID: 38794346 Free PMC article.

6

Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles-A Novel Strategy for Enhancement of the Anti-tumor Immune Response.

Markov O, Oshchepkova A, Mironova N. Markov O, et al. Front Pharmacol. 2019 Oct 11;10:1152. doi: 10.3389/fphar.2019.01152. eCollection 2019. Front Pharmacol. 2019. PMID: 31680949 Free PMC article. Review.

7

Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells.

Markov OV, Mironova NL, Vlasov VV, Zenkova MA. Markov OV, et al. Acta Naturae. 2016 Jul-Sep;8(3):17-30. Acta Naturae. 2016. PMID: 27795841 Free PMC article.

8

Tropism of Extracellular Vesicles and Cell-Derived Nanovesicles to Normal and Cancer Cells: New Perspectives in Tumor-Targeted Nucleic Acid Delivery.

Oshchepkova A, Markov O, Evtushenko E, Chernonosov A, Kiseleva E, Morozova K, Matveeva V, Artemyeva L, Vlassov V, Zenkova M. Oshchepkova A, et al. Pharmaceutics. 2021 Nov 11;13(11):1911. doi: 10.3390/pharmaceutics13111911. Pharmaceutics. 2021. PMID: 34834326 Free PMC article.

9

Dendritic Cell-Derived Artificial Microvesicles Inhibit RLS₄₀ Lymphosarcoma Growth in Mice via Stimulation of Th1/Th17 Immune Response.

Markov OV, Sen'kova AV, Mohamed IS, Shmendel EV, Maslov MA, Oshchepkova AL, Brenner EV, Mironova NL, Zenkova MA. Markov OV, et al. Pharmaceutics. 2022 Nov 21;14(11):2542. doi: 10.3390/pharmaceutics14112542. Pharmaceutics. 2022. PMID: 36432733 Free PMC article.

10

A Comparative Study of Different Protocols for Isolation of Murine Neutrophils from Bone Marrow and Spleen.

Sounbuli K, Alekseeva LA, Markov OV, Mironova NL. Sounbuli K, et al. Among authors: markov ov. Int J Mol Sci. 2023 Dec 8;24(24):17273. doi: 10.3390/ijms242417273. Int J Mol Sci. 2023. PMID: 38139101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page